These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1967513

  • 21. Effects of single and multiple doses of guanfacine in essential hypertension.
    Zamboulis C, Reid JL.
    Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
    [Abstract] [Full Text] [Related]

  • 22. Clinical pharmacology of centrally acting antihypertensive agents.
    Weber MA.
    J Clin Pharmacol; 1989 Jul; 29(7):598-602. PubMed ID: 2668350
    [Abstract] [Full Text] [Related]

  • 23. Effect of guanfacine on skills related to driving.
    Klebel E.
    Br J Clin Pharmacol; 1980 Jul; 10 Suppl 1(Suppl 1):173S-182S. PubMed ID: 6994773
    [Abstract] [Full Text] [Related]

  • 24. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg].
    Schäfer N, Knaup G.
    MMW Munch Med Wochenschr; 1982 Mar 12; 124(10):249-52. PubMed ID: 6806612
    [No Abstract] [Full Text] [Related]

  • 25. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
    Distler A, Kirch W, Lüth B.
    Br J Clin Pharmacol; 1980 Mar 12; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
    [Abstract] [Full Text] [Related]

  • 26. Pharmacology of guanfacine.
    Scholtysik G, Fetkovská N.
    Cor Vasa; 1987 Mar 12; 29(4 Suppl 1):11-6. PubMed ID: 2824129
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M, Overlack A, Stumpe KO.
    Br J Clin Pharmacol; 1980 Mar 12; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG, Bloxham CA, Walker JM.
    Pharmatherapeutica; 1981 Mar 12; 2(8):513-6. PubMed ID: 7019931
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
    Coves MJ, Gomis R, Casamitjana R, Lienas V, Vilaradell E.
    J Med; 1989 Mar 12; 20(3-4):291-6. PubMed ID: 2572660
    [Abstract] [Full Text] [Related]

  • 34. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I, Kállay K.
    Br J Clin Pharmacol; 1980 Mar 12; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [Abstract] [Full Text] [Related]

  • 35. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O, Polívková H.
    Cor Vasa; 1987 Mar 12; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [Abstract] [Full Text] [Related]

  • 36. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D, Bonelli J, Hitzenberger G, Kaik G.
    Arzneimittelforschung; 1980 Mar 12; 30(6):1005-7. PubMed ID: 6998487
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.